Fortescue Metals Group Ltd (FMG)

Size: px
Start display at page:

Download "Fortescue Metals Group Ltd (FMG)"

Transcription

1 3 March 2017 Analyst David Coates Authorisation Peter Arden Fortescue Metals Group Ltd (FMG) All about the iron ore price Recommendation Sell (unchanged) Price $6.62 Target (12 months) $5.75 (previously $3.80) Expected Return Capital growth -13.1% Dividend yield 7.3% Total expected return -5.9% Company Data & Ratios Enterprise value Market cap $25,867m $20,613m Issued capital 3,114m Free float 52% Avg. daily val. (52wk) $ month price range $2.29-$7.27 GICS sector Price Performance Materials (1m) (3m) (12m) Price (A$) Absolute (%) Rel market (%) Strong performance, dividend up FMG announced its 1HFY17 financial results, which were comfortably ahead of our estimates on account of the dramatic rise in the iron ore price compared to our forecast. As such, FMG reported Net Revenues of US$4,492m (vs BPe US$3,525m). While costs, D&A and interest charges were in-line with our estimates, the higher revenues flowed down to EBITDA of US$2,602m (vs BPe US$1,730m), EBIT of US$1,980m (vs BPe US$1,130m) and NPAT of US$1,222m (vs BPe US$743m). This also enabled a strong dividend of A20cps (fully franked) to be declared, equating to a payout ratio of 38%, up against the overall payout ratio for FY16 of 35% and ahead of our A10cps (fully franked) forecast. As at 31 Dec 16 FMG held cash of US$1,160m and gross debt of US$5,156m for net debt of US$4.0 billion. This followed debt repayments during the period of US$1.7 billion. FY17 guidance remains unchanged for Mt ore shipped at C1 cash costs of US$12-13/wmt. Making the most of an iron ore price windfall FMG certainly didn t fiddle while Rome was burning in 2015 when the iron ore price cratered. The unrelenting focus on cost reduction during that time has positioned FMG to generate free-cash-flows that nearly tripled over FY16 vs FY15 and in 1HFY17 have increased a further 59% on the pcp. During 1HFY17 further debt repayments of US$1,700m were made lowering net gearing to 30% and gross gearing to 36%. Investment thesis Sell (unch.), TP$5.75 (from $3.80) FMG continues to deliver on production guidance and impressive cost reductions. The operations haven t missed a beat in the last two years while this has been a focus. However, we remain of the view that much of this is priced in, together with the ongoing de-leveraging (we forecast FMG to be net cash in 1HFY19) and that FMG is being driven by the iron ore price rather than company specific catalysts. With the risk remaining to the downside for the iron ore price, we retain our sell recommendation, notwithstanding our NPV-based valuation increasing 52% to $5.75/sh. Absolute Price $8.0 $7.0 $6.0 $5.0 $4.0 $3.0 $2.0 $1.0 $0.0 Mar Jul 15 Nov SOURCE: IRESS FMG Mar 16 Jul 16 Nov 16 S&P 300 Rebased Earnings Forecast Year ending 30 Jun 2016a 2017e 2018e 2019e Sales (US$m) 7,083 9,346 8,247 7,768 EBITDA (US$m) 3,059 5,594 4,329 3,819 NPAT (reported) (US$m) 985 2,868 2,178 1,896 NPAT (adjusted) (US$m) 985 2,868 2,178 1,896 EPS (adjusted) (UScps) EPS growth (%) 212% 191% -24% -13% EPS (adjusted) (Acps) PER (x) EV/EBITDA (x) Dividend (Acps) Yield (%) 2% 7% 5% 4% Franking (%) 100% 100% 100% 100% ROE (%) 12% 27% 18% 14% SOURCE: BELL POTTER SECURITIES ESTIMATES BELL POTTER SECURITIES LIMITED ACN AFSL DISCLAIMER AND DISCLOSURES THIS REPORT MUST BE READ WITH THE DISCLAIMER AND DISCLOSURES ON PAGE 7 THAT FORM PART OF IT. Page 1

2 1HFY17 financial result Table 1 - FMG 1HFY17 financial result summary Key takeaways from the result FMG announced its 1HFY17 financial results, which were comfortably ahead of our estimates on account of the dramatic rise in the iron ore price against our price forecast. As such, FMG reported Net Revenues of US$4,492m (vs BPe US$3,525m). While costs, D&A and interest charges were in-line with our estimates, the higher revenues flowed down to EBITDA of US$2,602m (vs BPe US$1,730m), EBIT of US$1,980m (vs BPe US$1,130m) and NPAT of US$1,222m (vs BPe US$743m). This also enabled a strong dividend of A20cps (fully franked) to be declared, equating to a payout ratio of 38%, up against the overall payout ratio for FY16 of 35% and ahead of our A10cps (fully franked) forecast. As at 31 Dec 16 FMG held cash of US$1,160m and gross debt of US$5,156m for net debt of US$4.0 billion. This followed debt repayments during the period of US$1.7 billion. FY17 guidance remains unchanged for Mt ore shipped at C1 cash costs of US$12-13/wmt. Period Dec-15 Jun-16 Jun-16 Dec-16 Dec-16 Variance Variance Half / Full / BP Est HY(a) HY(a) FY(a) HY(a) HY (BPe) Vs pcp Vs FY(BPe) Revenue US$m 3,344 3,739 7,083 4,492 3,525 34% 27% EBITDA US$m 1,301 1,758 3,059 2,602 1, % 50% EBIT US$m 568 1,247 1,815 1,980 1, % 75% NPAT US$m , % 65% Dividend A$/sh % 100% Cash balance US$m 2,318 1,583 1,583 1,160 2,098-50% -45% Net debt US$m 6,130 5,188 5,188 3,996 4,580-35% -13% FMG ore shipped Mt (wet) % 2% SOURCE: COMPANY DATA AND BELL POTTER SECURITIES ESTIMATES Other key takeaways from the result include: CAPEX will start to increase as sustaining capital starts to increase towards long-run levels and renewal of mining fleets begins to commence. Construction of the Very Large Ore Carriers (VLOC s) has also had an impact; Free-cash-flows continue to grow strongly, having nearly tripled over FY16 vs FY15 and in 1HFY17 have increased a further 59% on the pcp; Over 1HFY17 the 62% benchmark iron ore price increased 27%, being the key driver of increased revenues for FMG and contributed 76% (US$1,016m) of the rise in underlying EBITDA vs the pcp; Iron ore prepayments were US$797m at 31 December 2016, scheduled to be amortised by US$350 million in FY18 and US$447 million in FY19; and Safety performance continues to improve, with the Total Reportable Injury Frequency Rate (TRIFR), falling 33% to 3.2 compared to the pcp. Page 2

3 Changes to our forecasts Beyond updating our forecasts for the 1HFY17 financial result we make the following changes to our modelling assumptions: Update for our latest iron ore price forecasts, which include material mark-to-market upgrades; Increase our medium term production forecasts in line with management commentary that incremental productivity gains would continue to lift production volumes; Increase our FY17 CAPEX forecasts in-line with management guidance of US$360m on ore carriers and tugs plus US$80m on exploration and development; Removed the reduced iron ore price discount we had forecast to commence in CY17 to reflect a possible blending deal with Vale. With no news on this and we have removed it from our forecasts; and Increase our near term dividend payout forecast to meet the top end of a guided 30%- 40% payout ratio. The net impact to our production and earnings estimates are summarised below. Table 2 - Changes to earnings estimates Previous New Change Year ending June 30 Jun-17 Jun-18 Jun-19 Jun-17 Jun-18 Jun-19 Jun-17 Jun-18 Jun-19 Iron ore (Fines) 62% Fe % 7% 0% AUD/USD % 0% 0% Total production (Mt wet) % 2% 4% Costs C1 (US$/t) % 0% 0% Revenue (US$m) 7,154 7,395 7,469 9,346 8,247 7,768 31% 12% 4% EBITDA (US$m) 3,587 3,635 3,355 5,594 4,329 3,819 56% 19% 14% NPAT (adjusted) (US$m) 1,610 1,727 1,623 2,868 2,178 1,896 78% 26% 17% Adjusted EPS (Ac/sh) % 26% 17% PER (x) (4.1) (1.9) (1.4) DPS (Ac/sh) % 83% 8% Yield (%) 4% 3% 4% 7% 5% 4% 4% 2% 0% Net debt (cash) ($m) 3,669 1, , (1,590) -38% -80% -1655% ND / (ND + E) (%) 28% 15% 1% 18% 3% -13% -10% -12% -14% Valuation ($/sh) % 52% 55% SOURCE: COMPANY DATA AND BELL POTTER SECURITIES ESTIMATES Our changes have led to significant near term earnings upgrades, primarily on the higher iron ore price assumptions and the modelling of a steadily increasing production profile. In FY17 a 30% increase to our assumed iron ore price (the bulk of which is due to mark-tomarket) is the main driver of a 78% increase to our earnings estimate, from US$1.6 billion to US$2.9 billion. In FY18 and FY19 earnings are upgraded 26% and 17% respectively. Upcoming catalysts Key near term catalysts for FMG include: Ongoing productivity and efficiency gains; Continued debt reduction and balance sheet improvement; CAPEX set to increase, ore carriers commencing service CY17; March 2017 production report; and Potential dividend increases. Page 3

4 Fortescue Metals Group Ltd (FMG) Company description: Iron ore major in the Pilbara, WA FMG is an independent iron ore producer in the Pilbara region of Western Australia. The company is currently achieving its targeted +165Mtpa production rate, following several years of development and expansion. There is potential for expansions beyond these rates, through optimising existing assets. The company s prime focus however has shifted to reducing its debt and achieving gross gearing levels of <40%. Investment thesis Sell (unch.), TP$5.75 (from $3.80) While cost and operating performance will continue to be optimised, the pace of improvement is expected to slow and become more incremental an entirely reasonable outlook. As such, there are few changes to our assumptions: a downward tweak to our strip ratios (for slightly lower mining costs) offset by a technical reduction in Ore Reserves and our NPV-based valuation is essentially unchanged. Earnings increase by 8% in FY17 and FY18 on the lower costs and our dividend forecast for FY17 increases to A24cps, from A14cps. We retain our sell recommendation. Valuation: $5.75/sh Our FMG valuation incorporates DCF models of FMG s Chichester and Solomon production hubs, a multiple valuation estimate of the Nyidinghu deposit, an estimate of exploration/expansion upside and an estimate of corporate overhead costs. Risks Risks to resources sector equities include, but are not limited to: - Commodity price and exchange rate fluctuations. The future earnings and valuations of exploration, development and operating resources companies are subject to fluctuations in underlying commodity prices and foreign currency exchange rates. - Infrastructure access. Bulk commodity producers are particularly reliant upon access to transport infrastructure. Access to infrastructure is often subject to contractual agreements, permits, and capacity allocations. Agreements are typically long-term in nature (+10 years). Infrastructure can be subject to outages as a result of weather events or the actions of third party providers. - Operating and capital cost fluctuations. Markets for exploration, development and mining inputs can fluctuate widely and cause significant differences between planned and actual operating and capital costs. Key operating costs are linked to energy and labour costs. - Resource growth and mine life extensions. Future earnings forecasts and valuations may rely upon resource and reserve growth to extend mine lives. - Sovereign risks. Mining companies assets can be located in countries other than Australia and are subject to the sovereign risks of that country. - Regulatory changes risks. Changes to the regulation of infrastructure and taxation (among other things) can impact the earnings and valuation of mining companies. - Operating and development risks. Mining companies assets are subject to risks associated with their operation and development. Risks for each company can be heightened depending on method of operation (e.g. underground versus open pit Page 4

5 mining) or whether it is a single operation company. Development assets can be subject to approvals timelines or weather events, causing delays to commissioning and commercial production. - Funding and capital management risks. Funding and capital management risks can include access to debt and equity finance, maintaining covenants on debt finance, managing dividend payments, and managing debt repayments. - Corporate/M&A risks. Risks associated with M&A activity including differences between the entity s and the market s perception of value associated with completed transactions. Page 5

6 Fortescue Metals Group Ltd Fortescue Metals Group Ltd (FMG) 3 March 2017 as at 3 March 2017 Recommendation Sell Price $6.62 Target (12 months) $5.75 Table 3 - Financial summary PROFIT AND LOSS FINANCIAL RATIOS Year ending 30 Jun Unit 2015a 2016a 2017e 2018e 2019e Year ending 30 Jun Unit 2015a 2016a 2017e 2018e 2019e Revenue US$m 8,574 7,083 9,346 8,247 7,768 VALUATION Expense US$m (6,120) (4,024) (3,752) (3,918) (3,949) NPAT (adjusted) US$m ,868 2,178 1,896 EBITDA US$m 2,454 3,059 5,594 4,329 3,819 Adjusted EPS USc/sh Depreciation US$m (1,405) (1,244) (1,215) (1,176) (1,201) EPS growth % 212% 191% -24% -13% EBIT US$m 1,049 1,815 4,380 3,153 2,619 Adjusted EPS Ac/sh Net interest expense US$m (629) (461) (361) (128) 15 EPS growth % 257% 184% -24% -13% PBT US$m 420 1,354 4,019 3,025 2,634 PER x 54.4x 15.2x 5.4x 7.1x 8.2x Tax expense US$m (104) (369) (1,150) (847) (737) DPS Ac/sh NPAT (reported) US$m ,868 2,178 1,896 Franking % 100% 100% 100% 100% 100% Abnormal items US$m Yield % 1% 2% 7% 5% 4% NPAT (adjusted) US$m ,868 2,178 1,896 FCF/share USc/sh FCF/share Ac/sh PROFIT AND LOSS (INTERIM) FCF yield % 4% 14% 24% 17% 16% Half year ending Unit Jun-16a Dec-16a Jun-17e Dec-17e Jun-18e EV/EBITDA x 8.5x 6.9x 3.7x 4.8x 5.5x Revenue US$m 3,739 4,492 4,854 4,263 3,984 EBITDA margin % 29% 43% 60% 52% 49% Expense US$m (1,981) (1,890) (1,862) (1,969) (1,948) EBIT margin % 12% 26% 47% 38% 34% EBITDA US$m 1,758 2,602 2,992 2,293 2,036 Return on assets % 1% 5% 15% 11% 10% Depreciation US$m (511) (622) (593) (588) (588) Return on equity % 4% 12% 27% 18% 14% EBIT US$m 1,247 1,980 2,400 1,705 1,448 LIQUIDITY & LEVERAGE Net interest expense US$m (321) (248) (113) (76) (52) Net debt (cash) US$m 7,188 5,188 2, (1,590) PBT US$m 926 1,732 2,287 1,630 1,395 ND / E % 95% 62% 21% 3% -12% Tax expense US$m (260) (510) (640) (456) (391) ND / (ND + E) % 49% 38% 18% 3% -13% NPAT (reported) US$m 666 1,222 1,646 1,174 1,005 ND / EBITDA x 2.9x 1.7x 0.4x 0.1x -0.4x Abnormal items US$m EBITDA/Interest x (258.5) NPAT (adjusted) US$m 666 1,222 1,646 1,174 1,005 ASSUMPTIONS - Prices CASH FLOW Year ending 30 Jun Unit 2015a 2016a 2017e 2018e 2019e Year ending 30 Jun Unit 2015a 2016a 2017e 2018e 2019e Iron ore (Fines) 62% Fe US$/dmt OPERATING CASHFLOW AUD/USD US$/A$ Receipts US$m 8,537 6,693 9,420 8,307 7,781 Long term (real) assumptions: IO (fines) 62% US$60/t, AUS/USD US$0.75/A$ Payments US$m (5,971) (3,736) (3,852) (3,891) (3,950) Tax US$m (529) 66 (905) (847) (737) ASSUMPTIONS - Production Net interest US$m (605) (627) (323) (128) 15 Year ending 30 Jun Unit 2015a 2016a 2017e 2018e 2019e Other US$m Sales (FMG equity) Mwt Operating cash flow US$m 1,432 2,396 4,340 3,441 3,108 Third party Mwt INVESTING CASHFLOW Sales (total) Mwt Capex & exploration US$m (849) (360) (719) (740) (645) 62% Fe index price US$/dt Other US$m (1) - - FMG realised price CFR US$/dt Investing cash flow US$m (726) (336) (720) (740) (645) Realised price discount % -18% -10% -14% -15% -15% FINANCING CASHFLOW Costs C1 (excl. royalty) US$/wt Net equity proceeds US$m Shipping US$/wt Debt proceeds US$m 2, Royalties US$/wt Debt repayments US$m (2,367) (2,695) (2,709) (1,000) (1,176) Other US$/wt Dividends US$m (343) (114) (638) (793) (508) Cost of sales US$/wt Other US$m (126) (26) Interest US$/wt Financing cash flow US$m (630) (2,835) (3,322) (1,793) (1,684) Capex (sustaining from FY15) US$/wt Change in cash US$m 76 (775) Total all-in cost US$/wt Total all-in cost (@ 8% moist) US$/dt BALANCE SHEET Total all-in cost (62% Fe eq.) US$/dt Year ending 30 Jun Unit 2015a 2016a 2017e 2018e 2019e ASSETS VALUATION Cash & short term investments US$m 2,381 1,583 1,879 2,787 3,567 Issued capital Accounts receivable US$m Shares on issue m 3,114 Inventory US$m Options (in the money) m 11 Property, plant & equipment US$m 12,979 12,305 16,343 15,877 15,291 Total m 3,125 Exploration & evaluation US$m 4,750 4, Jun-17 Jun-18 Jun-19 Other US$m Sum of parts valuation A$m $/sh A$m $/sh A$m $/sh Total assets US$m 21,360 19,337 19,194 19,605 19,816 Iron ore operations (DCF) 23, , , LIABILITIES Exploration (estimate) 1, , Accounts payable US$m Corporate (DCF) (897) (0.29) (856) (0.27) (811) (0.26) Borrowings US$m 9,569 6,771 4,153 3,153 1,977 Total enterprise value 24, , , Other US$m 3,515 3,538 3,857 3,857 3,857 Total liabilities US$m 13,823 10,931 8,568 7,594 6,417 Net debt/(cash) 5, , SHAREHOLDER'S EQUITY Equity value 19, , , Share capital US$m 1,294 1,301 1,283 1,283 1,283 Reserves US$m MAJOR SHAREHOLDERS Retained earnings US$m 6,184 7,058 9,292 10,677 12,065 Minderoo Group Pty Ltd 33% Non-controlling interest US$m Hunan Valin Iron & Steel Group 15% Total equity US$m 7,537 8,406 10,626 12,011 13,399 Other 52% Net debt US$m 7,188 5,188 2, (1,590) Weighted average shares m 3,114 3,112 3,114 3,114 3,114 SOURCE: BELL POTTER SECURITIES ESTIMATES Page 6

7 Recommendation structure Buy: Expect >15% total return on a 12 month view. For stocks regarded as Speculative a return of >30% is expected. Research Team Staff Member TS Lim Sam Haddad Jonathon Higgins Title/Sector Head of Research Phone tslim shaddad jhiggins Hold: Expect total return between -5% Chris Savage csavage and 15% on a 12 month view Jonathan Snape jsnape Sell: Expect <-5% total return on a 12 month view Tim Piper John Hester Tanushree Jain Healthcare Healthcare/Biotech tpiper jhester tnjain Speculative Investments are either start-up enterprises with nil or only prospective operations or recently commenced operations with only forecast cash flows, or companies that have commenced operations or have been in operation for some time but have only forecast cash flows and/or a stressed balance sheet. Financials TS Lim Lafitani Sotiriou Resources Peter Arden David Coates Associates James Filius Banks/Regionals Diversified Resources Resources Associate Analyst tslim lsotiriou parden dcoates jfilius Such investments may carry an exceptionally high level of capital risk and volatility of returns. Bell Potter Securities Limited ACN Level 38, Aurora Place 88 Phillip Street, Sydney 2000 Telephone The following may affect your legal rights. Important Disclaimer: This document is a private communication to clients and is not intended for public circulation or for the use of any third party, without the prior approval of Bell Potter Securities Limited. In the USA and the UK this research is only for institutional investors. It is not for release, publication or distribution in whole or in part to any persons in the two specified countries. In Hong Kong this research is being distributed by Bell Potter Securities (HK) Limited which is licensed and regulated by the Securities and Futures Commission, Hong Kong. This is general investment advice only and does not constitute personal advice to any person. Because this document has been prepared without consideration of any specific client s financial situation, particular needs and investment objectives ( relevant personal circumstances ), a Bell Potter Securities Limited investment adviser (or the financial services licensee, or the representative of such licensee, who has provided you with this report by arraignment with Bell Potter Securities Limited) should be made aware of your relevant personal circumstances and consulted before any investment decision is made on the basis of this document. While this document is based on information from sources which are considered reliable, Bell Potter Securities Limited has not verified independently the information contained in the document and Bell Potter Securities Limited and its directors, employees and consultants do not represent, warrant or guarantee, expressly or impliedly, that the information contained in this document is complete or accurate. Nor does Bell Potter Securities Limited accept any responsibility for updating any advice, views opinions, or recommendations contained in this document or for correcting any error or omission which may become apparent after the document has been issued. Except insofar as liability under any statute cannot be excluded. Bell Potter Limited and its directors, employees and consultants do not accept any liability (whether arising in contract, in tort or negligence or otherwise) for any error or omission in this document or for any resulting loss or damage (whether direct, indirect, consequential or otherwise) suffered by the recipient of this document or any other person. Disclosure of interest: Bell Potter Securities Limited, its employees, consultants and its associates within the meaning of Chapter 7 of the Corporations Law may receive commissions, underwriting and management fees from transactions involving securities referred to in this document (which its representatives may directly share) and may from time to time hold interests in the securities referred to in this document. ANALYST CERTIFICATION Each research analyst primarily responsible for the content of this research report, in whole or in part, certifies that with respect to each security or issuer that the analyst covered in this report: (1) all of the views expressed accurately reflect his or her personal views about those securities or issuers and were prepared in an independent manner and (2) no part of his or her compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed by that research analyst in the research report. Page 7

Platinum Asset Management (PTM)

Platinum Asset Management (PTM) 24 February 2017 Analyst Lafitani Sotiriou 613 9235 1668 Associate Analyst James Filius 613 9235 1612 Authorisation TS Lim 612 8224 2810 Recommendation Hold (unchanged) Price $5.10 Target (12 months) $4.90

More information

Perpetual (PPT) Oversold, upgrade to Buy. Over 6% yield, with upside in market rally. Quarterly highlights. Earnings revisions

Perpetual (PPT) Oversold, upgrade to Buy. Over 6% yield, with upside in market rally. Quarterly highlights. Earnings revisions 16 April 2018 Analyst Lafitani Sotiriou 613 9235 1668 Authorisation TS Lim 612 8224 2810 Perpetual (PPT) Oversold, upgrade to Buy Recommendation Buy (Hold) Price $42.09 Target (12 months) $47.50 (previously

More information

Adacel Technologies (ADA)

Adacel Technologies (ADA) 9 November 2018 Chris Savage 612 8224 2835 Authorisation TS Lim 612 8224 2810 Adacel Technologies (ADA) Bad, but not that bad Recommendation Buy (unchanged) Price $0.88 Target (12 months) $1.50 (previously

More information

Fortescue Metals Group (FMG)

Fortescue Metals Group (FMG) 30 October 2015 Analyst David Coates 612 8224 2887 Authorisation John Hester 612 8224 2871 Recommendation Buy (Hold) Price $2.09 Target (12 months) $2.40 (unchanged) Expected Return Capital growth 14.8%

More information

OneVue Holdings (OVH)

OneVue Holdings (OVH) 7 August 2017 Analyst Lafitani Sotiriou 613 9235 1668 Associate Analyst James Filius 613 9235 1612 Authorisation TS Lim 612 8224 2810 OneVue Holdings (OVH) FY17 result to show cost-out progress Recommendation

More information

BWX Limited (BWX) SOURCE: BELL POTTER SECURITIES ESTIMATES

BWX Limited (BWX) SOURCE: BELL POTTER SECURITIES ESTIMATES 9 February 2017 Analyst John O'Shea 613 9235 1633 Authorisation John Hester 612 8224 2871 Recommendation Buy (unchanged) Price $4.80 Target (12 months) $5.73 (unchanged) Expected Return Capital growth

More information

OneVue Holdings (OVH)

OneVue Holdings (OVH) 24 April 2018 Analyst Lafitani Sotiriou 613 9235 1668 Authorisation Peter Arden 613 9235 1833 OneVue Holdings (OVH) Restructured and focused Recommendation Buy (unchanged) Price $0.745 Target (12 months)

More information

Nanosonics (NAN) Preparing for new international markets. Maintain Hold, price target amended to $3.20 SOURCE: BELL POTTER SECURITIES ESTIMATES

Nanosonics (NAN) Preparing for new international markets. Maintain Hold, price target amended to $3.20 SOURCE: BELL POTTER SECURITIES ESTIMATES 21 February 2017 Analyst John Hester 612 8224 2871 Authorisation TS Lim 612 8224 2810 Nanosonics (NAN) Growth Slowly Emerging In Europe Recommendation Hold (unchanged) Price $2.80 Target (12 months) $3.20

More information

Aeon Metals Limited (AML)

Aeon Metals Limited (AML) Analyst David Coates 612 8224 2887 Authorisation Stuart Howe 613 9235 1856 Speculative See key risks on Page 4 Speculative securities may not be suitable for retail clients 22 March 2019 Aeon Metals Limited

More information

Mayne Pharma (MYX) Yet Another Transformational Acquisition. FY16 Earnings Confirmed. The company did not provide guidance in respect of FY17.

Mayne Pharma (MYX) Yet Another Transformational Acquisition. FY16 Earnings Confirmed. The company did not provide guidance in respect of FY17. 29 June 2016 Analyst John Hester 612 8224 2871 Authorisation TS Lim 612 8224 2810 Mayne Pharma (MYX) Merger Fallout Creates Opportunity Recommendation Buy (unchanged) Price $1.485 Target (12 months) $1.89

More information

Osprey (OSP) FY16 EBITDA Loss In Line. OSP has US$21.8m of cash as at 31 December Maintain Buy Rating And Valuation at $0.55

Osprey (OSP) FY16 EBITDA Loss In Line. OSP has US$21.8m of cash as at 31 December Maintain Buy Rating And Valuation at $0.55 27 February 2017 Analyst John Hester 612 8224 2871 Authorisation Tanushree Jain 612 8224 2849 Recommendation Buy (unchanged) Price $0.415 Valuation $0.55 (unchanged) Risk Speculative GICS Sector Healthcare

More information

Nanosonics (NAN) Summary of 2Q17 Cash Flows SOURCE: BELL POTTER SECURITIES ESTIMATES

Nanosonics (NAN) Summary of 2Q17 Cash Flows SOURCE: BELL POTTER SECURITIES ESTIMATES 16 January 2017 Analyst John Hester 612 8224 2871 Authorisation TS Lim 612 8224 2810 Nanosonics (NAN) US Market Continues To Expand Recommendation Hold (unchanged) Price $3.16 Target (12 months) $3.28

More information

Challenger (CGF) Expanding the potential. A broader and more robust business emerging. Earnings revisions SOURCE: BELL POTTER SECURITIES ESTIMATES

Challenger (CGF) Expanding the potential. A broader and more robust business emerging. Earnings revisions SOURCE: BELL POTTER SECURITIES ESTIMATES 14 February 2017 Analyst Lafitani Sotiriou 613 9235 1668 Associate Analyst James Filius 613 9235 1612 Authorisation TS Lim 612 8224 2810 Challenger (CGF) Expanding the potential Recommendation Buy (unchanged)

More information

Westgold Resources (WGX)

Westgold Resources (WGX) 3 September 2018 Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $1.36 Target (12 months) $2.15 (unchanged) Expected Return Capital growth

More information

ANZ Bank (ANZ) Unquestionably strong 1Q17. Healthy Jaws, safe to go back in the water SOURCE: BELL POTTER SECURITIES ESTIMATES

ANZ Bank (ANZ) Unquestionably strong 1Q17. Healthy Jaws, safe to go back in the water SOURCE: BELL POTTER SECURITIES ESTIMATES 17 February 2017 Analyst TS Lim 612 8224 2810 Authorisation Chris Savage 612 8224 2835 ANZ Bank (ANZ) Unquestionably strong 1Q17 Recommendation Buy (Hold) Price $30.21 Target (12 months) $33.25 (previously

More information

Metals X Limited (MLX)

Metals X Limited (MLX) 16 July 2018 Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $0.655 Target (12 months) $0.95 (previously $0.98) Expected Return Capital growth

More information

Auswide Bank (ABA) There are no tricks in plain and simple faith. 24 August : Underlying NPAT $17m, final dividend 18cps

Auswide Bank (ABA) There are no tricks in plain and simple faith. 24 August : Underlying NPAT $17m, final dividend 18cps 24 August 2018 TS Lim 612 8224 2810 Authorisation Tim Piper 612 8224 2825 Recommendation Buy (unchanged) Price $5.71 Target (12 months) $6.20 (previously $5.80) GICS Sector Banks Expected Return Capital

More information

Cyclopharm (CYC) Entry to US market inching closer. Maintain Buy Recommendation SOURCE: BELL POTTER SECURITIES ESTIMATES

Cyclopharm (CYC) Entry to US market inching closer. Maintain Buy Recommendation SOURCE: BELL POTTER SECURITIES ESTIMATES Analyst John Hester 612 8224 2871 Cyclopharm (CYC) 5 March 2018 Speculative See key risks on Page 4 and Biotechnology Risk Warning on Page 7. Speculative securities may not be suitable for Retail Clients.

More information

SurfStitch (SRF) Shaping the Surf industry. Acquisition in Product drives credibility. however we have some concerns

SurfStitch (SRF) Shaping the Surf industry. Acquisition in Product drives credibility. however we have some concerns 26 November 20 Analyst Sam Byrnes 612 8224 2886 Authorisation Chris Savage 612 8224 2835 SurfStitch (SRF) Shaping the Surf industry Recommendation Buy (unchanged) Price $2.06 Target (12 months) $2.65 (previously

More information

Metals X Limited (MLX)

Metals X Limited (MLX) 19 April 2018 Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $0.76 Target (12 months) $0.98 (previously $1.00) Expected Return Capital growth

More information

Metals X Limited (MLX)

Metals X Limited (MLX) 5 September 2018 Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $0.515 Target (12 months) $0.90 (previously $0.95) Expected Return Capital

More information

IPH Limited (IPH) Buy at the bottom

IPH Limited (IPH) Buy at the bottom 29 March 2017 Analyst Sam Haddad 612 8224 2819 Authorisation TS Lim 612 8224 2810 IPH Limited (IPH) Buy at the bottom Recommendation Buy (unchanged) Price $4.76 Target (12 months) $7.90 (unchanged) Expected

More information

Premier Investments (PMV)

Premier Investments (PMV) 16 March 2018 Analyst Sam Haddad 612 8224 2819 Authorisation Tim Piper 612 8224 2825 Premier Investments (PMV) Key growth pillars all strong Recommendation Buy (unchanged) Price $15.27 Target (12 months)

More information

ANZ Banking Group (ANZ)

ANZ Banking Group (ANZ) 1 May 2018 Analyst TS Lim 612 8224 2810 Authorisation Chris Savage 612 8224 2835 Recommendation Buy (unchanged) Price $27.47 Target (12 months) $30.20 (unchanged) GICS Sector Banks Expected Return Capital

More information

Galaxy Resources Ltd (GXY)

Galaxy Resources Ltd (GXY) 27 March 2018 Analyst Peter Arden 613 9235 1833 Authorisation Duncan Hughes 618 9326 7667 Galaxy Resources Ltd (GXY) Mt Cattlin doing what it is meant to Recommendation Buy Price $3.16 Price Target $4.75

More information

Breaker Resources NL (BRB)

Breaker Resources NL (BRB) David Coates 612 8224 2887 Authorisation Peter Arden 613 9235 1833 Speculative See key risks on Page 6. Speculative securities may not be suitable for retail clients 8 February 2019 Breaker NL (BRB) More

More information

Galaxy Resources Ltd (GXY)

Galaxy Resources Ltd (GXY) Analyst Peter Arden 613 9235 1833 Authorisation Duncan Hughes 618 9326 7667 Recommendation Buy (unchanged) Price $1.835 Valuation $3.35 (unchanged) -------------- Risk Speculative Expected Return Capital

More information

National Australia Bank (NAB)

National Australia Bank (NAB) 6 February 2017 Analyst TS Lim 612 8224 2810 Authorisation Chris Savage 612 8224 2835 Recommendation Buy (unchanged) Price $30.39 Target (12 months) $32.50 (previously $30.00) Expected Return Capital growth

More information

Commonwealth Bank (CBA)

Commonwealth Bank (CBA) 10 February 2016 Analyst TS Lim 612 8224 2810 Authorisation Chris Savage 612 8224 2835 Commonwealth Bank (CBA) Ordeal and triumph Recommendation Buy (unchanged) Price $74.20 Target (12 months) $83.50 (previously

More information

Peet Bonds (PPCHA) A yield uplift from fixed rate senior debt

Peet Bonds (PPCHA) A yield uplift from fixed rate senior debt 4 May 2016 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 (PPCHA) Authorisation TS Lim 612 8224 2810 Fixed Income Issue overview Issuer Issue ASX code Peet PPCHA Face value $100 Estimated

More information

Westgold Resources (WGX)

Westgold Resources (WGX) 7 February 2017 Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $2.25 Target (12 months) $2.60 Expected Return Capital growth 15.6% Dividend

More information

Osprey Medical (OSP)

Osprey Medical (OSP) 18 October 2017 Analyst John Hester 612 8224 2871 Authorisation TS Lim 612 8224 2810 Osprey Medical (OSP) Harvey and Irma Curtail Growth Speculative See key risks on Page 5 and Biotechnology Risk Warning

More information

Talisman Mining Ltd (TLM)

Talisman Mining Ltd (TLM) Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $0.41 Valuation $0.88 (previously $1.00) Risk Speculative Expected Return Capital growth

More information

Mesoblast (MSB) GVHD granted Fast Track, should benefit ongoing negotiations with Mallinckrodt

Mesoblast (MSB) GVHD granted Fast Track, should benefit ongoing negotiations with Mallinckrodt 7 March 2017 Analyst Tanushree Jain 612 8224 2849 Authorisation Chris Savage 612 8224 2835 Recommendation Buy (unchanged) Price $1.90 Valuation $3.22 (previously $3.17) Risk Speculative GICS Sector Pharmaceuticals

More information

Tech Sector. Updated key sells: None. Company Ticker Share price at Market Year end 22-Mar-17 cap FY17a/CY17e FY18e/CY18e FY17a/CY17e FY18e/CY18e

Tech Sector. Updated key sells: None. Company Ticker Share price at Market Year end 22-Mar-17 cap FY17a/CY17e FY18e/CY18e FY17a/CY17e FY18e/CY18e 22 March 2017 Analyst Chris Savage 612 8224 2835 Authorisation TS Lim 612 8224 2810 Tech Sector Key picks unchanged: IRI, APX, ADA & IFM Stock Price Target Rating ADA $2.37 $3.25 Buy ALU $7.41 $7.90 Hold

More information

Breaker Resources NL (BRB)

Breaker Resources NL (BRB) Analyst David Coates 612 8224 2887 Authorisation Peter Arden 613 9235 1833 Recommendation Buy (unchanged) Price $0.315 Valuation $0.96 (previously $1.30) Risk Speculative GICS Sector Materials Expected

More information

31 December 2013 Half year results February 2014

31 December 2013 Half year results February 2014 31 December 2013 Half year results February 2014 Disclaimer Important Notice The purpose of this presentation is to provide general information about Fortescue Metals Group Limited ("Fortescue"). It is

More information

Metals X Limited (MLX)

Metals X Limited (MLX) 1 November 2016 Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $1.38 Target (12 months) $2.10 (unchanged) Expected Return Capital growth

More information

Aspire Mining Ltd (AKM)

Aspire Mining Ltd (AKM) 4 June 2012 Analyst Stuart Howe 613 9235 1782 Fred Truong 613 9235 1629 Authorisation Jonathan Snape 613 9235 1601 Aspire Mining Ltd (AKM) Ovoot PFS released Recommendation Buy (unchanged) Price $0.13

More information

National Australia Bank (NAB)

National Australia Bank (NAB) 29 March 2016 Analyst TS Lim 612 8224 2810 Authorisation Chris Savage 612 8224 2835 Recommendation Buy (unchanged) Price $25.62 Target (12 months) $29.50 (unchanged) Expected Return Capital growth 15.1%

More information

St George Mining Ltd (SGQ)

St George Mining Ltd (SGQ) Analyst Peter Arden 613 9235 1833 Authorisation Duncan Hughes 618 9326 7667 Recommendation Buy (unchanged) Price $0.225 Valuation $0.30 (previously $0.26) Risk Speculative Expected Return Capital growth

More information

Half Year Financial Results to 31 December 2017

Half Year Financial Results to 31 December 2017 21 February 2018 Half Year Financial Results to 31 December 2017 Fortescue Metals Group Limited (ASX: FMG, Fortescue) Net profit of US$681 million and interim dividend of A$0.11 per share Fortescue has

More information

7.0% fully franked yield (expected 10.0% gross): Fixed until Nov 2018 reset date

7.0% fully franked yield (expected 10.0% gross): Fixed until Nov 2018 reset date 6 July 2012 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 William Spraggett 613 9235 1733 Whitefield Resettable Preference Shares (WHFPB) Authorisation John Gleeson 612 9255 7220

More information

Sustainable Competitive and Reliable Supplier of Iron Ore

Sustainable Competitive and Reliable Supplier of Iron Ore Sustainable Competitive and Reliable Supplier of Iron Ore Forward looking statements Disclaimer Important Notice The purpose of this presentation is to provide general information about Fortescue Metals

More information

Premier Investments (PMV)

Premier Investments (PMV) 4 April 2017 Analyst Sam Haddad 612 8224 2819 Authorisation TS Lim 612 8224 2810 Premier Investments (PMV) The Myers touch Recommendation Buy (unchanged) Price $14.20 Target (12 months) $17.65 (previously

More information

BUY SHARE PRICE CASH EARNINGS ($M) COMPANY DATA & RATIOS

BUY SHARE PRICE CASH EARNINGS ($M) COMPANY DATA & RATIOS BUY 0.11 0.39 0.69 SHARE PRICE CASH EARNINGS ($M) COMPANY DATA & RATIOS CONTENTS Competitors Products Sales channels Pricing Model INVESTMENT THESIS COMPANY OVERVIEW INDUSTRY OVERVIEW COMPETITORS BOARD

More information

UBS Investment Research Perseus Mining Limited

UBS Investment Research Perseus Mining Limited UBS Investment Research Perseus Mining Limited Small output miss on crusher downtime Event: September quarterly production report Sept Q output of 53koz was marginally below guidance of 55-60koz and the

More information

Asset revaluation driven by almonds

Asset revaluation driven by almonds Company update 20 July 2015 RURAL FUNDS GROUP (RFF) Asset revaluation driven by almonds We retain a BUY rating with a 12-month target of $1.15 p/unit. RFF is a listed property trust with a portfolio of

More information

Strike Energy Ltd (STX)

Strike Energy Ltd (STX) Analyst Peter Arden 613 9235 1833 Authorisation Stuart Howe 613 9235 1782 Recommendation Buy (unchanged) Price $0.115 Valuation $0.26 (previously $0.23) Risk Speculative Expected Return Capital growth

More information

Fortescue Metals Group

Fortescue Metals Group AUSTRALIA FMG AU Price (at 4:13, 31 Jan 217 GMT) Outperform A$6.6 Valuation A$ - DCF (WACC 8.5%, beta 1.3, ERP 5.%, RFR 3.3%) 4.91 12-month target A$ 7.6 12-month TSR % +19.1 Volatility Index High GICS

More information

Fortescue Metals Group

Fortescue Metals Group AUSTRALIA FMG AU Price (at 5:1, 5 Mar 215 GMT) Neutral A$2.29 Valuation A$ 2.6 - DCF (WACC 1.%, beta 1.4, ERP 5.%, RFR 3.8%, TGR 2.6%) 12-month target A$ 2.6 12-month TSR % +16. Volatility Index High GICS

More information

Pioneer Credit (PNC)

Pioneer Credit (PNC) 23 June 2014 Analyst Sam Byrnes 612 8224 2886 Authorisation Chris Savage 612 8224 2835 Pioneer Credit (PNC) Helping not chasing Recommendation Buy (Initiation) Price $1.55 Target (12 months) $1.80 Expected

More information

Paragon Care (PGC) Big Boxes, Big Opportunity. Capitalising on the burgeoning healthcare sector. Price leadership through quality

Paragon Care (PGC) Big Boxes, Big Opportunity. Capitalising on the burgeoning healthcare sector. Price leadership through quality 26 September 2014 Analyst John Hester 612 8224 2871 Authorisation TS Lim 612 8224 2810 Paragon Care (PGC) Big Boxes, Big Opportunity Recommendation Buy (Initiation) Price $0.33 Target (12 months) $0.38

More information

Value at the top end. Figure 1: Trading margins on debt and equity securities

Value at the top end. Figure 1: Trading margins on debt and equity securities 17 February 2012 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 Authorisation Steve Goldberg 612 8224 2809 Westpac Convertible Preference Shares (WBCPC) Fixed Interest Issue overview

More information

Mesoblast (MSB) Major CHF catalyst next week, Time to get on board

Mesoblast (MSB) Major CHF catalyst next week, Time to get on board 9 November 2018 Analyst Tanushree Jain 612 8224 2849 Authorisation John Hester 612 8224 2871 Recommendation Buy (unchanged) Price $2.18 Valuation $4.06 (previously $3.95) Risk Speculative GICS Sector Pharmaceuticals

More information

Fortescue Metals Group

Fortescue Metals Group AUSTRALIA FMG AU Price (at 5:1, 17 Feb 217 GMT) Outperform A$6.88 Valuation A$ - DCF (WACC 8.5%, beta 1.3, ERP 5.%, RFR 3.3%) 4.96 12-month target A$ 7.6 12-month TSR % +14.9 Volatility Index High GICS

More information

Talisman Mining Ltd (TLM)

Talisman Mining Ltd (TLM) Analyst Peter Arden 613 9235 1833 Authorisation David Coates 612 8224 2887 Recommendation Buy (unchanged) Price $0.29 Valuation $0.67 (previously $0.88) Risk Speculative Expected Return Capital growth

More information

2011 Interim Results. Keith Gordon, Managing Director & Chief Executive Officer Stephen Gobby, Chief Financial Officer

2011 Interim Results. Keith Gordon, Managing Director & Chief Executive Officer Stephen Gobby, Chief Financial Officer 2011 Interim Results Keith Gordon, Managing Director & Chief Executive Officer Stephen Gobby, Chief Financial Officer Emeco 2011 Interim Results Overview Financials Strategy & Outlook Questions Appendices

More information

Fortescue Metals Group

Fortescue Metals Group Fortescue Metals Group March 2019 Together we are Fortescue Forward looking statements Disclaimer Important Notice The purpose of this presentation is to provide general information about Fortescue Metals

More information

BUY PLS SHARE PRICE (A$) US$650/T COMPANY DATA & RATIOS. A$m FY18 FY19 FY20 FY21. Source: Blue Ocean estimates

BUY PLS SHARE PRICE (A$) US$650/T COMPANY DATA & RATIOS. A$m FY18 FY19 FY20 FY21. Source: Blue Ocean estimates PILBARA MINERALS (PLS) Funding in place, FID imminent, Time to Buy Analyst Email Phone Date Steuart McIntyre steuartmcintyre@boeq.com.au +61 2 8072 2909 22 June 2017 We say Price Target Strategic Target

More information

Fortescue Metals Group

Fortescue Metals Group AUSTRALIA FMG AU Price (at 6:1, 17 Jul 212 GMT) Outperform A$4.54 Volatility index Medium 12month target A$ 7.6 12month TSR % +7.6 Valuation A$ 7.58 DCF (WACC 1.5%, beta 1.6, ERP 5.%, RFR 5.%, TGR 3.%)

More information

UBS Investment Research Brambles Limited

UBS Investment Research Brambles Limited UBS Investment Research Brambles Limited FY12 result: strong revenue momentum Result highlights strong revenue momentum Brambles FY12 result was slightly ahead of expectations, revealing 11% underlying

More information

MEDICAL DEVELOPMENTS INTERNATIONAL LTD

MEDICAL DEVELOPMENTS INTERNATIONAL LTD MEDICAL DEVELOPMENTS INTERNATIONAL LTD No pain in Germany HOLD Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals 6 April 2018 COMPANY UPDATE Ticker MVP Stock Price $7.10 Target Price $8.08

More information

China Iron Ore Beijing, 4 February 2015

China Iron Ore Beijing, 4 February 2015 China Iron Ore 2015 Beijing, 4 February 2015 Disclaimer Important Notice The purpose of this presentation is to provide general information about Fortescue Metals Group Limited ("Fortescue"). It is not

More information

Fortescue Metals Group

Fortescue Metals Group AUSTRALIA FMG AU Price (at 3:1, 22 Feb 217 GMT) Outperform A$6.99 Valuation A$ - DCF (WACC 8.5%, beta 1.3, ERP 5.%, RFR 3.3%) 4.79 12-month target A$ 7.6 12-month TSR % +13.2 Volatility Index High GICS

More information

Oz Minerals. Solid start to the year A$5.62 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Oz Minerals. Solid start to the year A$5.62 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation AUSTRALIA OZL AU Price (at 6:24, 21 Apr 216 GMT) Underperform A$5.62 Valuation A$ - DCF (WACC 1%, beta 1.4, ERP 5.%, RFR 3.8%) 4.61 12-month target A$ 4.6 12-month TSR % -15.5 Volatility Index High GICS

More information

WINDLAB LTD HOLD. Lakeland financial close delayed again. Downgrade to HOLD. COMPANY UPDATE EVENT IMPACT INVESTMENT VIEW

WINDLAB LTD HOLD. Lakeland financial close delayed again. Downgrade to HOLD. COMPANY UPDATE EVENT IMPACT INVESTMENT VIEW WINDLAB LTD HOLD Lakeland financial close delayed again. Downgrade to HOLD. Utilities / Renewable Electricity 7 November 2018 COMPANY UPDATE Ticker WND Stock Price $1.180 Target Price $1.350 Forecast Capital

More information

Boart Longyear. Earnings and target price revision. No change. Price catalyst. Action and recommendation

Boart Longyear. Earnings and target price revision. No change. Price catalyst. Action and recommendation AUSTRALIA BLY AU Price (at 08:01, 12 Sep 2013 GMT) Neutral A$0.50 Valuation A$ 0.71 - DCF (WACC 10.1%, beta 1.5, ERP 0.1%, RFR 0.1%, TGR 0.0%) 12-month target A$ 0.56 12-month TSR % +12.0 Volatility Index

More information

Macquarie Group Capital Notes 2 (MQGPB) * MANDATORY CONVERSION IS SUBJECT TO SATISFYING THE MANDATORY CONVERSION CONDITIONS

Macquarie Group Capital Notes 2 (MQGPB) * MANDATORY CONVERSION IS SUBJECT TO SATISFYING THE MANDATORY CONVERSION CONDITIONS 23 November 2015 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 Authorisation Macquarie Group Capital Notes 2 (MQGPB) TS Lim 612 8224 2810 Fixed Interest Issue overview Issuer Issue

More information

Alumina. Earnings and target price revision. Price catalyst. Action and recommendation

Alumina. Earnings and target price revision. Price catalyst. Action and recommendation AUSTRALIA AWC AU Price (at 10:25, 16 Aug 2012 GMT) Outperform A$0.73 Volatility index High 12-month target A$ 1.30 12-month TSR % +78.5 Valuation A$ - DCF (WACC 10.3%, beta 1.3, ERP 5.0%, RFR 6.5%) 2.25

More information

Australian Mid-cap Iron-Ore

Australian Mid-cap Iron-Ore AUSTRALIA Recommendation changes None BC Iron Outperform Price $0.23 Market Cap A$45m Target Price $0.35 TSR 52% Mt Gibson Iron Neutral Price $0.18 Market Cap A$196m Target Price $0.25 TSR 39% Grange Resources

More information

Cash Converters Intl.

Cash Converters Intl. MICROCAP COMPANY RESEARCH Cash Converters Intl. 22 nd November 2012 GICS: Diversified Financials Consumer Finance 1Q13 Trading Update RECENT NEW S Cash Converters [ASX:CCV] recently provided a trading

More information

Challenger. Normalised margin trends expected to decline. Earnings and target price revision. Price catalyst. Action and recommendation

Challenger. Normalised margin trends expected to decline. Earnings and target price revision. Price catalyst. Action and recommendation 1H13E 2H13E 1H14E 2H14E 1H15E 2H15E AUSTRALIA CGF AU Price (at CLOSE#, 20 Aug 2012) Outperform A$3.76 Volatility index Low 12-month target A$ 4.57 12-month TSR % +26.4 Valuation - Sum of Parts A$ 4.57

More information

Figure 1: ASX listed debt redemptions Figure 2: Trading margins on debt and equity securities

Figure 1: ASX listed debt redemptions Figure 2: Trading margins on debt and equity securities 8 February 2017 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 Authorisation (NABPE) TS Lim 612 8224 2810 Fixed Income Issue overview Issuer Issue ASX code NAB NABPE Face value $100

More information

Consolidated Operations Group (COG)

Consolidated Operations Group (COG) Consolidated Operations Group (COG) 10 April 2018 Outperform Upgrade to OUTPERFORM - Inflection point nearing $0.10 Jason Palmer jpalmer@taylorcollison.com.au +618 8217 3965 Summary (AUD) Market Capitalisation

More information

QBE Insurance. QBE ANZ performance: LMI vs. Excl. LMI (A$m) Source: Company data, Macquarie Research, April 16. Earnings and target price revision

QBE Insurance. QBE ANZ performance: LMI vs. Excl. LMI (A$m) Source: Company data, Macquarie Research, April 16. Earnings and target price revision AUSTRALIA QBE AU Price (at 10:44, 27 Apr 2016 GMT) Neutral A$11.19 Valuation A$ - DCF (WACC 9.3%, beta 1.1, ERP 5.0%, RFR 3.8%) 11.34 12-month target A$ 12.00 12-month TSR % +12.7 Volatility Index Low/Medium

More information

Fortescue Metals Group

Fortescue Metals Group AUSTRALIA FMG AU Price (at 08:49, 24 Jun 20 GMT) Outperform A$3.27 Valuation A$ - DCF (WACC 9.6%, beta 1.4, ERP 5.0%, RFR 3.3%) 3.57 12-month target A$ 3.60 12-month TSR % +.9 Volatility Index Very High

More information

ONEVIEW HEALTHCARE PLC

ONEVIEW HEALTHCARE PLC ONEVIEW HEALTHCARE PLC BUY 2017 Result Green Shoots Emerging Health Care Equipment & Services / Health Care Technology 28 February 2018 COMPANY UPDATE Ticker ONE Stock Price $1.900 Target Price $3.04 Forecast

More information

MotorCycle Holdings (MTO) New HOLD: Harley still lacking traction. Key points. Risks and catalysts

MotorCycle Holdings (MTO) New HOLD: Harley still lacking traction. Key points. Risks and catalysts Date Theme Company Update Company MotorCycle Holdings (MTO) New HOLD: Harley still lacking traction We moderate to HOLD (from Buy) with a revised target of $2.36 p/share. We were previously encouraged

More information

Ride the recovery. Figure 1: Trading margins on debt and equity securities. (prior to exchange) over BBSW Mand Conv* Call

Ride the recovery. Figure 1: Trading margins on debt and equity securities. (prior to exchange) over BBSW Mand Conv* Call 17 May 2016 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 Authorisation TS Lim 612 8224 2810 Fixed Income Issue overview Issuer Issue ASX code BELL POTTER SECURITIES LIMITED ACN

More information

Oz Minerals. Raises copper production outlook A$9.08 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

Oz Minerals. Raises copper production outlook A$9.08 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst AUSTRALIA OZL AU Price (at 7:28, 3 Jan 27 GMT) Neutral A$9.8 Valuation A$ - DCF (WACC 9.%, beta.4, ERP 5.%, RFR 3.3%) 8.48 2-month target A$ 9.3 2-month TSR % +4.6 Volatility Index High GICS sector Materials

More information

Australian Iron Ore Miners

Australian Iron Ore Miners AUSTRALIA BHP Billiton Neutral Market Cap US$69,410m Price A$18.55/ 8.48/ZAR182.75 Price Target A$15.50/ 7.20/ZAR163 TSR (15%)/(13%)/(9%) Rio Tinto Outperform Market Cap US$56,484m Price A$46.47/ 21.05

More information

Sandfire Resources. Swings to net cash A$5.34 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Sandfire Resources. Swings to net cash A$5.34 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation AUSTRALIA SFR AU Price (at 6:11, 7 Jul 216 GMT) Outperform A$5.34 Valuation A$ - DCF (WACC 9.%, beta 1.4, ERP 5.%, RFR 3.3%) 5.82 12-month target A$ 6.1 12-month TSR % +18.3 Volatility Index Medium GICS

More information

Resetting expectations

Resetting expectations Company update 13 May 2016 TPI ENTERPRISES (TPE) Resetting expectations We retain a BUY rating with a revised 12-month price target of $3.21 p/sh. We assess market conditions to imply a more gradual ramp

More information

Generation Healthcare REIT

Generation Healthcare REIT AUSTRALIA GHC AU Price (at 06:13, 24 Aug 2015 GMT) Neutral A$1.65 Valuation - Sum of Parts A$ 1.51-1.59 12-month target A$ 1.59 12-month TSR % +1.8 Volatility Index Low GICS sector Real Estate Market cap

More information

MMG. A year of consolidation in 2017 AUSTRALIA/HONG KONG. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

MMG. A year of consolidation in 2017 AUSTRALIA/HONG KONG. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation AUSTRALIA/HONG KONG AU / 128 HK Outperform Price (at 4:, 13 Mar 217 GMT) A$4.9/HK$2.85 Valuation - DCF (WACC 7.%, ERP 5.%, RFR 3.3%) A$4.86/HK$2.85 12-month target A$5.5/HK$3.2 12-month TSR % +12.2 Volatility

More information

Negotiating Cyclone project buy in

Negotiating Cyclone project buy in 4 July 2017 Negotiating Cyclone project buy in Cape Bedford : High quality silica sand Recommendation Strong BUY, High Risk Price Valuation Products : 0.7c 6.5c Mineral Sands (Zircon rich) Silica sand

More information

BUY DCN SHARE PRICE FORECAST PRODUCTION & COSTS COMPANY DATA & RATIOS. koz - FY18 FY19 FY20 FY21 FY22.

BUY DCN SHARE PRICE FORECAST PRODUCTION & COSTS COMPANY DATA & RATIOS. koz - FY18 FY19 FY20 FY21 FY22. DACIAN GOLD LIMITED (DCN) INCREASING PRICE TARGET TO $3.30 Analyst Email Phone Date Steuart McIntyre steuartmcintyre@boeq.com.au +61 2 8072 2909 21 June 2016 We say Price Target Strategic Target BUY 2.45

More information

BUY SHARE PRICE CHART FORECAST OPERATING CASHFLOW COMPANY DATA & RATIOS. A$m - CY20 CY21 CY22 CY23 CY24 CY25

BUY SHARE PRICE CHART FORECAST OPERATING CASHFLOW COMPANY DATA & RATIOS. A$m - CY20 CY21 CY22 CY23 CY24 CY25 SHEFFIELD RESOURCES (SFX) Upgrading Price Target to $1.70 Analyst Email Phone Date Steuart McIntyre steuartmcintyre@boeq.com.au +61 2 8072 2909 6 November 2017 We say Price Target Strategic Target BUY

More information

Regis Resources. Strong 1H15 result A$1.29 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Regis Resources. Strong 1H15 result A$1.29 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation AUSTRALIA RRL AU Price (at 7:29, 13 2 GMT) Outperform A$1.29 Valuation A$ - DCF (WACC 9.%, beta 1.5, ERP 5.%, RFR 3.8%) 1.68 12-month target A$ 1.7 12-month TSR % +37.2 Volatility Index High GICS sector

More information

Orocobre. Upside exposure fading. Earnings and target price revision. Price catalyst. Catalyst: Update on projects or Q1 report

Orocobre. Upside exposure fading. Earnings and target price revision. Price catalyst. Catalyst: Update on projects or Q1 report AUSTRALIA ORE AU Price (at 5:11, 28 Feb 217 GMT) Neutral A$3.8 Valuation - DCF (WACC 1.%) A$ 1.34 12-month target A$ 3.17 12-month TSR % +2.9 Volatility Index High GICS sector Materials Market cap A$m

More information

16-Jan Jul Oct Apr Sep Feb Dec Aug Nov May-09

16-Jan Jul Oct Apr Sep Feb Dec Aug Nov May-09 16-Mar-09 16-Apr-09 16-May-09 16-Jun-09 16-Jul-09 16-Aug-09 16-Sep-09 16-Oct-09 16-Nov-09 16-Dec-09 16-Jan-10 16-Feb-10 200 180 160 140 120 100 80 60 40 20 0 PJ 2014 2015 2016 2017 2018 2019 BG 90 60

More information

Nanosonics (NAN) 1H17: Cash earnings beat grabs attention. Key points

Nanosonics (NAN) 1H17: Cash earnings beat grabs attention. Key points Date 21 February 2017 Theme Financial Results Company Nanosonics (NAN) 1H17: Cash earnings beat grabs attention We maintain our BUY rating with a revised price target of $3.72 per share. NAN shares have

More information

Mt Morgan site visit - Hitting targets

Mt Morgan site visit - Hitting targets Deutsche Bank Markets Research Rating Buy Australasia Australia Company Reuters Bloomberg Exchange Ticker DCN.AX DCN AU ASX DCN Mt Morgan site visit - Hitting targets DCN on time and budget to deliver

More information

Figure 1: Bell Potter fair value assessment. 2.40%: July 2018 Fixed Rate Senior Bond (OTC yield 6.00%)

Figure 1: Bell Potter fair value assessment. 2.40%: July 2018 Fixed Rate Senior Bond (OTC yield 6.00%) 13 August 2012 Analysts Damien Williamson 613 9235 1958 Barry Ziegler 613 9235 1848 Authorisation John Gleeson 612 9255 7220 Fixed Interest Issue overview Issuer Issue ASX code Crown CWNHA Face value $100

More information

AtCor Medical Holdings Limited (ACG)

AtCor Medical Holdings Limited (ACG) Volume (million) AtCor Medical Holdings Limited (ACG) 30 March 2015 Speculative Buy Value Creation Ahead Post CPT1 Code Award $0.20 Marcus Hamilton mhamilton@taylorcollison.com.au +61 2 9210 1317 Summary

More information

Finders Resources Limited (FND) BUY Share Price:

Finders Resources Limited (FND) BUY Share Price: Finders Resources Limited (FND) BUY Share Price: A$0.17 The cheapest copper stock on the ASX? Target Price: A$0.42 Finders Resources is the cheapest ASX listed copper producer on P/E, FCF yield and EV/EBITDA

More information

Independence Group NL

Independence Group NL AUSTRALIA IGO AU Price (at 12:29, 26 Oct 216 GMT) Outperform A$4.25 Valuation A$ - DCF (WACC 8.4%, beta 1.2, ERP 5.%, RFR 3.3%) 3.98 12-month target A$ 5. 12-month TSR % +2.2 Volatility Index High GICS

More information

Generation Healthcare REIT All about spread Event

Generation Healthcare REIT All about spread Event AUSTRALIA GHC AU Price (at 04:51, 14 Feb 2015 GMT) Neutral A$1.60 Valuation - Sum of Parts A$ 1.18-1.26 12-month target A$ 1.59 12-month TSR % +5.1 Volatility Index Low GICS sector Real Estate Market cap

More information

Company Review. Centaurus Metals. Jambreiro Resource upgrade. CTM A$0.08 Recommendation Buy Risk Assessment High

Company Review. Centaurus Metals. Jambreiro Resource upgrade. CTM A$0.08 Recommendation Buy Risk Assessment High Company Review Ord Minnett Research Friday, June 24, 2011 Centaurus Metals Jambreiro Resource upgrade Centaurus has upgraded the JORC resource at its flagship, Jambreiro Iron Ore Project in Brazil. The

More information